Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

22. September 2014 08:30 ET | Quelle: AIM ImmunoTech Inc.

Hemispherx Announces Primate Research Showing Alferon(R) LDO Protection From Pulmonary Damage Associated With Infection by Highly Pathogenic Influenza Virus

PHILADELPHIA, Sept. 22, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today a peer-reviewed publication entitled "Protection from...
07. Januar 2014 08:30 ET | Quelle: AIM ImmunoTech Inc.

Hemispherx Biopharma Reports Evidence Based Clinical Potential of a Natural Interferon (IFN) -- Alpha for Infection Control and Treatment of Drug Resistant H7N9 Influenza Virus

PHILADELPHIA, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") today announced publication of an article entitled "Emergence of a novel drug...
21. März 2006 10:05 ET | Quelle: Smart-tek Solutions Inc.

Smart-tek Solutions, Inc. Completes Successful Demonstration in China of Its Proprietary System to Monitor Poultry Flocks That May Be Subject to Avian Flu

CORTE MADERA, Calif., March 21, 2006 (PRIMEZONE) -- Smart-tek Communications, Inc. announced today the successful completion of a demonstration in the People's Republic of China of its RFID tracking...